WuXi Girds For Rising Yuan, Weakening U.S. Dollar

WuXi PharmTech believes it is prepared, unlike some of its Chinese outsourcing competitors, for the expected appreciation of the Chinese yuan, which could affect business from U.S. firms as the dollar weakens and it becomes more expensive to outsource to China